These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 20211701

  • 1. Relationships among gender, age, time, and temperature in methamphetamine-induced striatal dopaminergic neurotoxicity.
    Dluzen DE, McDermott JL, Darvesh AS.
    Neuroscience; 2010 Jun 02; 167(4):985-93. PubMed ID: 20211701
    [Abstract] [Full Text] [Related]

  • 2. The effect of gender and the neurotrophin, BDNF, upon methamphetamine-induced neurotoxicity of the nigrostriatal dopaminergic system in mice.
    Dluzen DE.
    Neurosci Lett; 2004 Apr 15; 359(3):135-8. PubMed ID: 15050682
    [Abstract] [Full Text] [Related]

  • 3. Parity decreases methamphetamine-induced striatal dopaminergic perturbation.
    Dluzen DE.
    Neurochem Int; 2011 Aug 15; 59(2):101-3. PubMed ID: 21693145
    [Abstract] [Full Text] [Related]

  • 4. Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice.
    Lewis C, Dluzen DE.
    Neurosci Lett; 2008 Dec 19; 448(1):130-3. PubMed ID: 18852023
    [Abstract] [Full Text] [Related]

  • 5. Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system.
    Liu B, Dluzen DE.
    Synapse; 2006 Oct 19; 60(5):354-61. PubMed ID: 16838362
    [Abstract] [Full Text] [Related]

  • 6. Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice.
    Liu B, Dluzen DE.
    Neuroendocrinology; 2006 Oct 19; 83(5-6):295-302. PubMed ID: 16926530
    [Abstract] [Full Text] [Related]

  • 7. Sex differences in dopamine- and vesicular monoamine-transporter functions.
    Dluzen DE, McDermott JL.
    Ann N Y Acad Sci; 2008 Oct 19; 1139():140-50. PubMed ID: 18991858
    [Abstract] [Full Text] [Related]

  • 8. Markers associated with testosterone enhancement of methamphetamine-induced striatal dopaminergic neurotoxicity.
    Buletko AB, Dluzen DE, McDermott JL, Darvesh AS, Geldenhuys WJ.
    Neurotoxicol Teratol; 2012 Oct 19; 34(3):338-43. PubMed ID: 22521941
    [Abstract] [Full Text] [Related]

  • 9. Sex differences in methamphetamine-evoked striatal dopamine of mice are reversed by nomifensine.
    Kunnathur V, Shemisa K, Liu B, Salvaterra TJ, Dluzen DE.
    Neurotoxicol Teratol; 2006 Oct 19; 28(5):557-62. PubMed ID: 16978834
    [Abstract] [Full Text] [Related]

  • 10. Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity.
    Bourque M, Liu B, Dluzen DE, Di Paolo T.
    Biochem Pharmacol; 2007 Nov 01; 74(9):1413-23. PubMed ID: 17825264
    [Abstract] [Full Text] [Related]

  • 11. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N, Ares-Santos S, Oliva I, O'Shea E, Martin ED, Colado MI, Moratalla R.
    Neurobiol Dis; 2011 Jun 01; 42(3):391-403. PubMed ID: 21303698
    [Abstract] [Full Text] [Related]

  • 12. [Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
    Abekawa T.
    Hokkaido Igaku Zasshi; 1997 Jan 01; 72(1):113-26. PubMed ID: 9086367
    [Abstract] [Full Text] [Related]

  • 13. Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure.
    Miller DB, O'Callaghan JP, Ali SF.
    Ann N Y Acad Sci; 2000 Sep 01; 914():194-207. PubMed ID: 11085321
    [Abstract] [Full Text] [Related]

  • 14. Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content.
    Crawford CA, Williams MT, Newman ER, McDougall SA, Vorhees CV.
    Synapse; 2003 Jun 01; 48(3):131-7. PubMed ID: 12645038
    [Abstract] [Full Text] [Related]

  • 15. Developmental and genetic influences upon gender differences in methamphetamine-induced nigrostriatal dopaminergic neurotoxicity.
    Dluzen DE, McDermott JL.
    Ann N Y Acad Sci; 2004 Oct 01; 1025():205-20. PubMed ID: 15542719
    [Abstract] [Full Text] [Related]

  • 16. Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation.
    McConnell SE, O'Banion MK, Cory-Slechta DA, Olschowka JA, Opanashuk LA.
    Neurotoxicology; 2015 Sep 01; 50():131-41. PubMed ID: 26283213
    [Abstract] [Full Text] [Related]

  • 17. Gender-dependent enhanced adult neurotoxic response to methamphetamine following fetal exposure to the drug.
    Heller A, Bubula N, Lew R, Heller B, Won L.
    J Pharmacol Exp Ther; 2001 Aug 01; 298(2):769-79. PubMed ID: 11454941
    [Abstract] [Full Text] [Related]

  • 18. Further studies of the role of hyperthermia in methamphetamine neurotoxicity.
    Bowyer JF, Davies DL, Schmued L, Broening HW, Newport GD, Slikker W, Holson RR.
    J Pharmacol Exp Ther; 1994 Mar 01; 268(3):1571-80. PubMed ID: 8138969
    [Abstract] [Full Text] [Related]

  • 19. The impact of gender and estrogen on striatal dopaminergic neurotoxicity.
    Miller DB, Ali SF, O'Callaghan JP, Laws SC.
    Ann N Y Acad Sci; 1998 May 30; 844():153-65. PubMed ID: 9668673
    [Abstract] [Full Text] [Related]

  • 20. Sex differences in methamphetamine-evoked striatal dopamine output are abolished following gonadectomy: comparisons with potassium-evoked output and responses in prepubertal mice.
    Dluzen DE, Salvaterra TJ.
    Neuroendocrinology; 2005 May 30; 82(2):78-86. PubMed ID: 16415598
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.